Trial Outcomes & Findings for A Comparison of Dexmedetomidine Versus Propofol for Use in Intravenous Sedation (NCT NCT03255824)
NCT ID: NCT03255824
Last Updated: 2020-05-13
Results Overview
To compare the groups regarding the number of respiratory events requiring intervention, described as: Chin lift/jaw thrust, Tongue thrust, Yankauer suctioning, Positive pressure oxygen administration, Placement of an oral or nasal airway.
COMPLETED
PHASE4
144 participants
During surgery
2020-05-13
Participant Flow
Participant milestones
| Measure |
Propofol Group
Group of patients to be administered a standard Propofol, Midazolam, Fentanyl anesthesia combination.
Propofol, Midazolam, and Fentanyl: Administration of Propofol, Midazolam, and Fentanyl for sedation during third molar surgery.
|
Dexmedetomidine Group
Group of patients to be administered the Dexmedetomidine and Midazolam anesthesia combination.
Dexmedetomidine and Midazolam: Administration of Dexmedetomidine and Midazolam for sedation during third molar surgery.
|
|---|---|---|
|
Overall Study
STARTED
|
69
|
75
|
|
Overall Study
COMPLETED
|
67
|
74
|
|
Overall Study
NOT COMPLETED
|
2
|
1
|
Reasons for withdrawal
| Measure |
Propofol Group
Group of patients to be administered a standard Propofol, Midazolam, Fentanyl anesthesia combination.
Propofol, Midazolam, and Fentanyl: Administration of Propofol, Midazolam, and Fentanyl for sedation during third molar surgery.
|
Dexmedetomidine Group
Group of patients to be administered the Dexmedetomidine and Midazolam anesthesia combination.
Dexmedetomidine and Midazolam: Administration of Dexmedetomidine and Midazolam for sedation during third molar surgery.
|
|---|---|---|
|
Overall Study
Under-sedation
|
2
|
1
|
Baseline Characteristics
Race/Ethnicity Not Collected
Baseline characteristics by cohort
| Measure |
Propofol Group
n=69 Participants
Group of patients to be administered a standard Propofol, Midazolam, Fentanyl anesthesia combination.
Propofol, Midazolam, and Fentanyl: Administration of Propofol, Midazolam, and Fentanyl for sedation during third molar surgery.
|
Dexmedetomidine Group
n=75 Participants
Group of patients to be administered the Dexmedetomidine and Midazolam anesthesia combination.
Dexmedetomidine and Midazolam: Administration of Dexmedetomidine and Midazolam for sedation during third molar surgery.
|
Total
n=144 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Continuous
|
21.3 years
STANDARD_DEVIATION 2.7 • n=69 Participants
|
21.4 years
STANDARD_DEVIATION 2.5 • n=75 Participants
|
21.4 years
STANDARD_DEVIATION 2.7 • n=144 Participants
|
|
Sex: Female, Male
Female
|
50 Participants
n=69 Participants
|
46 Participants
n=75 Participants
|
96 Participants
n=144 Participants
|
|
Sex: Female, Male
Male
|
19 Participants
n=69 Participants
|
29 Participants
n=75 Participants
|
48 Participants
n=144 Participants
|
|
Ethnicity (NIH/OMB)
Hispanic or Latino
|
0 Participants
Race/Ethnicity Not Collected
|
0 Participants
Race/Ethnicity Not Collected
|
0 Participants
Race/Ethnicity Not Collected
|
|
Ethnicity (NIH/OMB)
Not Hispanic or Latino
|
0 Participants
Race/Ethnicity Not Collected
|
0 Participants
Race/Ethnicity Not Collected
|
0 Participants
Race/Ethnicity Not Collected
|
|
Ethnicity (NIH/OMB)
Unknown or Not Reported
|
0 Participants
Race/Ethnicity Not Collected
|
0 Participants
Race/Ethnicity Not Collected
|
0 Participants
Race/Ethnicity Not Collected
|
|
Body Mass Index (BMI)
|
25.3 kg/m^2
STANDARD_DEVIATION 5.2 • n=69 Participants
|
26.1 kg/m^2
STANDARD_DEVIATION 5.4 • n=75 Participants
|
25.7 kg/m^2
STANDARD_DEVIATION 5.4 • n=144 Participants
|
|
Number of Impactions
|
3.6 Impacted Teeth
STANDARD_DEVIATION 0.5 • n=69 Participants
|
3.6 Impacted Teeth
STANDARD_DEVIATION 0.5 • n=75 Participants
|
3.6 Impacted Teeth
STANDARD_DEVIATION 0.5 • n=144 Participants
|
PRIMARY outcome
Timeframe: During surgeryTo compare the groups regarding the number of respiratory events requiring intervention, described as: Chin lift/jaw thrust, Tongue thrust, Yankauer suctioning, Positive pressure oxygen administration, Placement of an oral or nasal airway.
Outcome measures
| Measure |
Propofol Group
n=67 Participants
Group of patients to be administered a standard Propofol, Midazolam, Fentanyl anesthesia combination.
Propofol, Midazolam, and Fentanyl: Administration of Propofol, Midazolam, and Fentanyl for sedation during third molar surgery.
|
Dexmedetomidine Group
n=74 Participants
Group of patients to be administered the Dexmedetomidine and Midazolam anesthesia combination.
Dexmedetomidine and Midazolam: Administration of Dexmedetomidine and Midazolam for sedation during third molar surgery.
|
|---|---|---|
|
Respiratory Events Requiring Intervention
|
17 Participants
|
2 Participants
|
SECONDARY outcome
Timeframe: During the first injection of local anesthesia during surgeryTo compare the groups regarding movement of the patient during the first injection of local anesthesia during the IVS at time of injection measured using the Behavioral Pain Scale - Non-Intubated patients. The minimum value is 3 and the maximum value is 12. Higher scores mean a worse outcome (i.e., more pain and movement on injection)
Outcome measures
| Measure |
Propofol Group
n=67 Participants
Group of patients to be administered a standard Propofol, Midazolam, Fentanyl anesthesia combination.
Propofol, Midazolam, and Fentanyl: Administration of Propofol, Midazolam, and Fentanyl for sedation during third molar surgery.
|
Dexmedetomidine Group
n=74 Participants
Group of patients to be administered the Dexmedetomidine and Midazolam anesthesia combination.
Dexmedetomidine and Midazolam: Administration of Dexmedetomidine and Midazolam for sedation during third molar surgery.
|
|---|---|---|
|
Reaction to Administration of Local Anesthesia
|
3.9 score on a scale
Standard Deviation 1.5
|
4.2 score on a scale
Standard Deviation 1.4
|
SECONDARY outcome
Timeframe: 30 minutes following surgeryVisual Analog Scale was used to measure overall satisfaction with the IV sedation and memory of the procedure. The minimum score is 0 (not satisfied at all) to a maximum score of 100 (completely satisfied). A higher score is a better outcome.
Outcome measures
| Measure |
Propofol Group
n=67 Participants
Group of patients to be administered a standard Propofol, Midazolam, Fentanyl anesthesia combination.
Propofol, Midazolam, and Fentanyl: Administration of Propofol, Midazolam, and Fentanyl for sedation during third molar surgery.
|
Dexmedetomidine Group
n=74 Participants
Group of patients to be administered the Dexmedetomidine and Midazolam anesthesia combination.
Dexmedetomidine and Midazolam: Administration of Dexmedetomidine and Midazolam for sedation during third molar surgery.
|
|---|---|---|
|
Patient Satisfaction
|
93.5 score on a scale
Standard Deviation 10.1
|
86.6 score on a scale
Standard Deviation 22.0
|
SECONDARY outcome
Timeframe: 15 minutes following surgerySurgeon satisfaction was measured by the surgeon grading the "Operating Conditions" scale. The minimum value was 0 and the maximum was 3. 0=very poor, 1=poor, 2=fair, 3=good
Outcome measures
| Measure |
Propofol Group
n=67 Participants
Group of patients to be administered a standard Propofol, Midazolam, Fentanyl anesthesia combination.
Propofol, Midazolam, and Fentanyl: Administration of Propofol, Midazolam, and Fentanyl for sedation during third molar surgery.
|
Dexmedetomidine Group
n=74 Participants
Group of patients to be administered the Dexmedetomidine and Midazolam anesthesia combination.
Dexmedetomidine and Midazolam: Administration of Dexmedetomidine and Midazolam for sedation during third molar surgery.
|
|---|---|---|
|
Surgeon Satisfaction - Survey
|
2.8 score on a scale
Standard Deviation 0.5
|
2.9 score on a scale
Standard Deviation 0.4
|
SECONDARY outcome
Timeframe: 15 minutes following surgerySurgeon satisfaction is measured by the Cooperation Scale. Minimum score of 0 and maximum of 9. Higher indicates a worse outcome (i.e., discomfort and movement)
Outcome measures
| Measure |
Propofol Group
n=67 Participants
Group of patients to be administered a standard Propofol, Midazolam, Fentanyl anesthesia combination.
Propofol, Midazolam, and Fentanyl: Administration of Propofol, Midazolam, and Fentanyl for sedation during third molar surgery.
|
Dexmedetomidine Group
n=74 Participants
Group of patients to be administered the Dexmedetomidine and Midazolam anesthesia combination.
Dexmedetomidine and Midazolam: Administration of Dexmedetomidine and Midazolam for sedation during third molar surgery.
|
|---|---|---|
|
Cooperation Scale
|
2.07 score on a scale
Standard Deviation 1.95
|
1.47 score on a scale
Standard Deviation 1.68
|
SECONDARY outcome
Timeframe: During the procedure, up to 40 minutesTo compare the differences in hemodynamic stability using a D/M combination compared to the MFP combination. (In this study, a deviation from baseline of both the blood pressure and heart rate by 20% or greater will be considered clinically significant) a. Change in heart rate (change ≥ 20 BPM)
Outcome measures
| Measure |
Propofol Group
n=67 Participants
Group of patients to be administered a standard Propofol, Midazolam, Fentanyl anesthesia combination.
Propofol, Midazolam, and Fentanyl: Administration of Propofol, Midazolam, and Fentanyl for sedation during third molar surgery.
|
Dexmedetomidine Group
n=74 Participants
Group of patients to be administered the Dexmedetomidine and Midazolam anesthesia combination.
Dexmedetomidine and Midazolam: Administration of Dexmedetomidine and Midazolam for sedation during third molar surgery.
|
|---|---|---|
|
Hemodynamic Stability - Heart Rate
|
77 beats per minute
Standard Deviation 14.20
|
62 beats per minute
Standard Deviation 12.28
|
SECONDARY outcome
Timeframe: During the procedure, up to 40 minutesTo compare the differences in hemodynamic stability using a D/M combination compared to the MFP combination. (In this study, a deviation from baseline by 20% or greater will be considered clinically significant) a. Change in blood pressure (NIBP) (change ≥ 20%) Blood pressure is presented as mean arterial pressure
Outcome measures
| Measure |
Propofol Group
n=67 Participants
Group of patients to be administered a standard Propofol, Midazolam, Fentanyl anesthesia combination.
Propofol, Midazolam, and Fentanyl: Administration of Propofol, Midazolam, and Fentanyl for sedation during third molar surgery.
|
Dexmedetomidine Group
n=74 Participants
Group of patients to be administered the Dexmedetomidine and Midazolam anesthesia combination.
Dexmedetomidine and Midazolam: Administration of Dexmedetomidine and Midazolam for sedation during third molar surgery.
|
|---|---|---|
|
Hemodynamic Stability - Blood Pressure
|
78 mm Hg
Standard Deviation 12.4
|
88 mm Hg
Standard Deviation 9.25
|
SECONDARY outcome
Timeframe: During the procedure, up to 40 minutesTo assess whether a D/M combination leads to a significant change in respiratory depression compared to the MFP combination. a. Change in respiratory rate (change ≥ 20%)
Outcome measures
| Measure |
Propofol Group
n=67 Participants
Group of patients to be administered a standard Propofol, Midazolam, Fentanyl anesthesia combination.
Propofol, Midazolam, and Fentanyl: Administration of Propofol, Midazolam, and Fentanyl for sedation during third molar surgery.
|
Dexmedetomidine Group
n=74 Participants
Group of patients to be administered the Dexmedetomidine and Midazolam anesthesia combination.
Dexmedetomidine and Midazolam: Administration of Dexmedetomidine and Midazolam for sedation during third molar surgery.
|
|---|---|---|
|
Respiratory Depression - Respiratory Rate
|
18 breaths per minute
Standard Deviation 4.38
|
18 breaths per minute
Standard Deviation 3.61
|
SECONDARY outcome
Timeframe: During the procedure, up to 40 minutesTo assess whether a D/M combination leads to a significant change in respiratory depression compared to the MFP combination. a. Change in arterial oxygen saturation (as measured by pulse oximeter) i. number of events of ≤92%
Outcome measures
| Measure |
Propofol Group
n=67 Participants
Group of patients to be administered a standard Propofol, Midazolam, Fentanyl anesthesia combination.
Propofol, Midazolam, and Fentanyl: Administration of Propofol, Midazolam, and Fentanyl for sedation during third molar surgery.
|
Dexmedetomidine Group
n=74 Participants
Group of patients to be administered the Dexmedetomidine and Midazolam anesthesia combination.
Dexmedetomidine and Midazolam: Administration of Dexmedetomidine and Midazolam for sedation during third molar surgery.
|
|---|---|---|
|
Respiratory Depression - Oxygen Saturation
|
98.7 Saturation percent
Standard Deviation 1.03
|
98.9 Saturation percent
Standard Deviation 0.37
|
SECONDARY outcome
Timeframe: During the procedure, up to 40 minutesTo assess whether a D/M combination increases postoperative recovery time when compared the MFP combination. a. Duration of procedure will be recorded
Outcome measures
| Measure |
Propofol Group
n=67 Participants
Group of patients to be administered a standard Propofol, Midazolam, Fentanyl anesthesia combination.
Propofol, Midazolam, and Fentanyl: Administration of Propofol, Midazolam, and Fentanyl for sedation during third molar surgery.
|
Dexmedetomidine Group
n=74 Participants
Group of patients to be administered the Dexmedetomidine and Midazolam anesthesia combination.
Dexmedetomidine and Midazolam: Administration of Dexmedetomidine and Midazolam for sedation during third molar surgery.
|
|---|---|---|
|
Postoperative Recovery Time - Duration of Procedure
|
24.2 MINUTES
Standard Deviation 13.9
|
22.1 MINUTES
Standard Deviation 8.8
|
SECONDARY outcome
Timeframe: After the procedure until ambulation, up to 20 minutesTo assess whether a D/M combination increases postoperative recovery time when compared the MFP combination. a. Time to ambulation (to recovery room) will be recorded
Outcome measures
| Measure |
Propofol Group
n=67 Participants
Group of patients to be administered a standard Propofol, Midazolam, Fentanyl anesthesia combination.
Propofol, Midazolam, and Fentanyl: Administration of Propofol, Midazolam, and Fentanyl for sedation during third molar surgery.
|
Dexmedetomidine Group
n=74 Participants
Group of patients to be administered the Dexmedetomidine and Midazolam anesthesia combination.
Dexmedetomidine and Midazolam: Administration of Dexmedetomidine and Midazolam for sedation during third molar surgery.
|
|---|---|---|
|
Postoperative Recovery Time - Ambulation
|
10.8 minutes
Standard Deviation 8.6
|
11.6 minutes
Standard Deviation 6.4
|
SECONDARY outcome
Timeframe: After the procedure until discharge, up to 45 minutesTo assess whether a D/M combination increases postoperative recovery time when compared the MFP combination. a. Time to discharge or "virtual discharge" (comparative statistic) - Aldrete score of ≥ 9 or pre-procedure score is met The minimum score is 0 and the maximum score is 10. A higher score indicates wakefulness, hemodynamically stable, and able to ambulate. ii. All subjects are required to stay a minimum of 30 minutes after the end of the procedure. Therefore, at least two postoperative vital sign readings will be obtained. If the subject meets discharge criteria prior to 30 minutes, this time will be the "virtual discharge" time
Outcome measures
| Measure |
Propofol Group
n=67 Participants
Group of patients to be administered a standard Propofol, Midazolam, Fentanyl anesthesia combination.
Propofol, Midazolam, and Fentanyl: Administration of Propofol, Midazolam, and Fentanyl for sedation during third molar surgery.
|
Dexmedetomidine Group
n=74 Participants
Group of patients to be administered the Dexmedetomidine and Midazolam anesthesia combination.
Dexmedetomidine and Midazolam: Administration of Dexmedetomidine and Midazolam for sedation during third molar surgery.
|
|---|---|---|
|
Postoperative Recovery Time - Time to Discharge
|
26.5 minutes
Standard Deviation 14.9
|
29.9 minutes
Standard Deviation 12.9
|
Adverse Events
Propofol Group
Dexmedetomidine Group
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place